Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;14(1):67-85.
doi: 10.34172/apb.2024.018. Epub 2023 Oct 14.

Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement

Affiliations
Review

Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement

Rifath Sheikh Vaseem et al. Adv Pharm Bull. 2024 Mar.

Abstract

The skin is the body's largest organ and serves as a site of administration for various medications. Transdermal drug delivery systems have several advantages over traditional delivery systems. It has both local and systemic therapeutic properties. Controlled plasma drug levels, reduced dosing frequency, and avoidance of hepatic first-pass metabolism are just a few of these systems' advantages. To achieve maximum efficacy, it is critical to understand the kinetics, physiochemical properties of the drug moiety, and drug transport route. This manuscript focused on the principles of various physical means to facilitate transdermal drug delivery. Some examples are iontophoresis, electrophoresis, photomechanical waves, ultrasound, needleless injections, and microneedles. Mechanical, chemical, magnetic, and electrical energy are all used in physical methods. A major advantage of physical methods is their capability to abbreviate pain, which can be used for effective disease management. Further investigation should be carried out at the clinical level to understand these methods for effective drug delivery.

Keywords: Advanced techniques; Facilitated transdermal drug delivery; Transcellular mechanism; Transdermal.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5
Figure 6
Figure 6
Figure 7
Figure 7

References

    1. Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica (Cairo) 2016;2016:8525679. doi: 10.1155/2016/8525679. - DOI - PMC - PubMed
    1. Lang X, Wang T, Sun M, Chen X, Liu Y. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: a review. Int J Biol Macromol. 2020;154:433–45. doi: 10.1016/j.ijbiomac.2020.03.148. - DOI - PubMed
    1. Morales JO, Fathe KR, Brunaugh A, Ferrati S, Li S, Montenegro-Nicolini M, et al. Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes. AAPS J. 2017;19(3):652–68. doi: 10.1208/s12248-017-0054-z. - DOI - PubMed
    1. Hafeez A, Jain U, Singh J, Maurya A, Rana L. Recent advances in transdermal drug delivery system (TDDS): an overview. J Sci Innov Res. 2013;2(3):695–709.
    1. Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug DelivTransl Res. 2022;12(4):758–91. doi: 10.1007/s13346-021-00909-6. - DOI - PMC - PubMed

LinkOut - more resources